Sutro Biopharma Inc. (STRO)
NASDAQ: STROHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 14.66 0.00%
STRO stock chart
Technical analysisKey statistics
All statistics- Market cap
- $243.08M
- EPS (TTM)
- -$17.28
- Dividend yield
- None
- 52-week range
- 7.15 – 43.85
- Day range
- 14.01 – 15.73
- Volume / Avg
- 232.53K / 289.73K
- Beta
- —
- Shares outstanding
- 16.58M
- Next earnings
- Nov 5, 2026
52-week range
STRO stock today
Sutro Biopharma (STRO) closed at $14.66 on Oct 7, up 1.45% (+$0.21), versus the S&P 500's 0.22% decline. At this level, STRO sits in the middle of its 52-week range of $7.15 to $43.85: 66.6% below the high, set on May 15, 2026 and 105.0% above the low. STRO is up 26.7% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 74.5%.
Sutro Biopharma has posted a net loss over the last twelve months (EPS of -$17.28), so its P/E ratio is not meaningful. Sutro Biopharma's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Sutro Biopharma
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- IPO year
- 2018
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $-1.88
Sutro Biopharma peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| LCTXLineage Cell Therapeutics Inc. | 0.9476 | +1.03% | $239.66M | vs STRO |
| IPSCCentury Therapeutics Inc. | 1.28 | -3.03% | $231.78M | vs STRO |
| FATEFate Therapeutics Inc. | 2.15 | -6.11% | $257.61M | vs STRO |
| PALIPalisade Bio Inc. | 1.48 | -0.67% | $257.92M | vs STRO |
| PLXProtalix BioTherapeutics Inc. (DE) | 2.71 | -0.73% | $218.35M | vs STRO |
| SABSSAB Biotherapeutics Inc. | 2.88 | -1.71% | $262.04M | vs STRO |
| IVVDInvivyd Inc. | 0.7286 | -9.65% | $214.76M | vs STRO |
| ALECAlector Inc. | 1.92 | +6.08% | $214.38M | vs STRO |
Indexes, lists and sector
Largest Health Care stocks
Sutro Biopharma stock FAQ
What is Sutro Biopharma's stock price today?
STRO last traded at $14.66 as of Oct 7, 4:00 PM EDT, up 1.45% on the day. Prices are delayed at least 15 minutes.
Does Sutro Biopharma pay a dividend?
No. Sutro Biopharma does not currently pay a regular cash dividend.
When is Sutro Biopharma's next earnings date?
Sutro Biopharma is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $-1.88.
Has STRO ever split its stock?
Yes. The most recent STRO stock split was a 1-for-10 split on Dec 3, 2025.
What is the STRO 52-week high?
The 52-week high for STRO is $43.85 and the 52-week low is $7.15. The stock is currently 66.6% below its high.